NCT05358210

Brief Summary

This randomized, parallel-design trial will evaluate specific clinical and physiological effects of whole blueberries in adults 70 years of age or older.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 20, 2022

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 21, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 3, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 22, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 22, 2024

Completed
Last Updated

July 18, 2024

Status Verified

July 1, 2024

Enrollment Period

2.1 years

First QC Date

April 21, 2022

Last Update Submit

July 16, 2024

Conditions

Keywords

BlueberriesDatesOlder AdultsBlood pressureFruitVascular healthDietitian

Outcome Measures

Primary Outcomes (4)

  • Ambulatory Blood Pressure Monitoring

    24-hour wake-time ambulatory blood pressure monitoring

    12 weeks after randomization

  • Orthostatic Hypotension

    Supine and standing blood pressure

    12-weeks after randomization

  • Lower Extremity Functioning

    Short Physical Performance Battery

    12 weeks after randomization

  • Cognition

    Cogstate Brief Battery of four core cognitive domains: processing speed, attention, visual learning, and working memory

    12 weeks after randomization

Secondary Outcomes (18)

  • Number of Self-Reported Falls

    Weekly for 12 weeks between baseline and follow-up

  • Grip Strength

    12 weeks after randomization

  • Sleep

    12 weeks after randomization

  • Incontinence

    12 weeks after randomization

  • Cardiac Ectopy

    12 weeks after randomization

  • +13 more secondary outcomes

Other Outcomes (5)

  • Liver Enzymes

    12 weeks after randomization

  • Total and Direct Bilirubin

    12 weeks after randomization

  • Fasting Glucose

    12 weeks after randomization

  • +2 more other outcomes

Study Arms (2)

Blueberry Consumption

EXPERIMENTAL

Randomized participants will consume 1 cup of frozen blueberries, provided by the trial, daily for 12 weeks.

Behavioral: Blueberry Consumption

Dried Date Consumption

ACTIVE COMPARATOR

Randomized participants will consume 2-3 dried dates, provided by the trial, daily for 12 weeks.

Behavioral: Dried Date Consumption

Interventions

Participants will consume 1 cup of frozen blueberries daily for the 12 weeks of the intervention. The study dietitian will provide educational materials and monitor compliance through weekly check-ins. Participants will be instructed to avoid all other high-anthocyanin foods including other berries, cherries, currants, cabbage, red wine, and eggplant.

Blueberry Consumption

Participants will consume 2-3 dried dates daily for the 12 weeks of the intervention, an isocaloric portion of fruit compared to the blueberry group. The study dietitian will provide educational materials and monitor compliance through weekly check-ins. Participants will be instructed to avoid all other high-anthocyanin foods including blueberries, other berries, cherries, currants, cabbage, red wine, and eggplant.

Dried Date Consumption

Eligibility Criteria

Age70 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • years old
  • Independent-living

You may not qualify if:

  • Cardiovascular event or procedure within 3 months of randomization
  • AHA Class III-IV heart failure
  • Intolerance or allergy to blueberries or dates
  • History of gastric bypass surgery
  • Any planned hospitalization or vacation in the ensuing 4 months
  • Any current cancer treatment
  • End-stage renal disease
  • Any organ transplant
  • Uncontrolled diabetes mellitus with hemoglobin A1c \>9%
  • Systolic blood pressure \>200 mmHg
  • Inability to provide personal informed consent (e.g. cognitive impairment)
  • Investigator concern

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Center Communities of Brookline (CCB)

Brookline, Massachusetts, 02446, United States

Location

NewBridge on the Charles

Dedham, Massachusetts, 02026, United States

Location

MeSH Terms

Conditions

Hypotension, OrthostaticVascular Diseases

Condition Hierarchy (Ancestors)

Orthostatic IntolerancePrimary DysautonomiasAutonomic Nervous System DiseasesNervous System DiseasesHypotensionCardiovascular Diseases

Study Officials

  • Kenneth J Mukamal, MD, MPH

    Beth Israel Deaconess Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Individual, parallel-design, randomized trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Section Chief for Research

Study Record Dates

First Submitted

April 21, 2022

First Posted

May 3, 2022

Study Start

April 20, 2022

Primary Completion

May 22, 2024

Study Completion

May 22, 2024

Last Updated

July 18, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations